Cargando…
MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers
Transcription factor AP-2 alpha (AP-2α or TFAP2A) is a newly identified prognostic marker of chemotherapy; its expression is positively correlated with chemosensitivity and survival of cancer patients. Using computational programs, we predicted that the coding region of AP-2α gene contains a potenti...
Autores principales: | Zhou, Ji, Duan, Huaxin, Xie, Yu, Ning, Yichong, Zhang, Xing, Hui, Na, Wang, Chunqing, Zhang, Jian, Zhou, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039396/ https://www.ncbi.nlm.nih.gov/pubmed/27698912 http://dx.doi.org/10.7150/jca.15620 |
Ejemplares similares
-
The miR-193a-5p/NCX2/AKT axis promotes invasion and metastasis of osteosarcoma
por: Chen, Ruiqi, et al.
Publicado: (2021) -
MAEL contributes to gastric cancer progression by promoting ILKAP degradation
por: Zhang, Xing, et al.
Publicado: (2017) -
A miR-200b/200c/429-Binding Site Polymorphism in the 3′ Untranslated Region of the AP-2α Gene Is Associated with Cisplatin Resistance
por: Wu, Yuan, et al.
Publicado: (2011) -
ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
por: Ning, Yichong, et al.
Publicado: (2019) -
CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression
por: Ning, Yichong, et al.
Publicado: (2019)